Jaleva Pharmaceuticals at OneMedForum 2010
Mordy Levine, CEO of Jaleva Pharmaceuticals, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
Cantimer at OneMedForum 2010
Robin Stracey, President and CEO of Cantimer, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
Quantum Immunologics at the 2010 OneMedForum
Charles Broes, CEO and Chairman of the Board of Quantum Immunologics, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San […]
NeoMatrix at the 2010 OneMedForum
John Stroh, CEO of NeoMatrix, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
Ocular Therapeutix at the 2010 OneMedForum
Amar Sawhney, President and CEO of Ocular Therapeutix, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
HydraDx at OneMedForum 2010
Frank Bellizzi, President and CEO of HydraDx, discusses his company at the 2010 OneMedForum conference.
LifeTech Capital Recommends NovaBay Pharmaceuticals
NovaBay of Emeryville, Calif., develops antimicrobial products for a variety of infections, including conjunctivitis, MRSA, the skin disease impetigo, and urinary tract infections.
Sinus Patients May Benefit from Surgery, Study Finds
A new study by Oregon Health and Science University indicates that minimally invasive surgery can significantly benefit adults with chronic sinusitis.
Diabetes Drug Wins Approval, Helps the Competition
The approval of Novo Nordisk’s diabetes drug Victoza has led to an unintended benefit for a competitor.
ImmunoCellular Therapeutics at the 2010 OneMedForum
Manish Singh, President and CEO of ImmunoCellular Therapeutics, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.